Gal-3 plasma levels in patients with the first acute NSTEMI were significantly higher in preexisting AF patients compared to non-AF patients. Gal-3 levels also have shown a significant and independent predictive value of recurrence after RF ablation for AF
Preoperative Gal-3 levels were significantly higher in the POAF group compared to patients without POAF (9.60 ± 6.83 ng/mL vs. 7.10 ± 3.54 ng/mL; p-value < 0.001)
An optimal pair of cytokines, including Gal-3 and others (e.g., CXL-10, CXCL-10, GDF-15, and RETN), exhibited the highest MCC (Matthews’ correlation coefficient) values
Note: Data are presented as mean ± standard deviation or median (interquartile range). CAD, coronary artery disease; AMI, acute myocardial infarction; MI, myocardial infarction; Gal-3, galectin-3; AF, atrial fibrillation; NSTEMI , non-ST elevation myocardial infarction; RF, radiofrequency; CRP, C-reactive protein; NOAF, new-onset atrial fibrillation; POAF, postoperative atrial fibrillation; LVEF, left ventricular ejection fraction; CABG, coronary artery bypass grafting.